Tumour-induced angiogenesis: a novel target for drug therapy?
- 1 June 1997
- journal article
- Published by Informa Healthcare in Emerging Drugs
- Vol. 2 (1) , 175-190
- https://doi.org/10.1517/14728214.2.1.175
Abstract
The ability of a tumour to induce the formation of new blood vessels has a profound effect on tumour growth. The formation of new blood vessels, a process termed angiogenesis, permits rapid expansion of a tumour and increases the risk of metastatic spread. The concept that tumour growth is dependent on the formation of new blood vessels as a source of nutrients and oxygen has stimulated an interest in understanding the basic mechanisms involved in angiogenesis and has formed the basis for a novel therapeutic strategy against cancer. Studies over the past 25 years have begun to elucidate the mechanisms involved in vascular cell proliferation, motility and differentiation leading to the formation of new blood vessels. These studies have unravelled a new array of targets for new drug discovery and therapeutic intervention. A number of molecules that induce angiogenesis and a variety of others that inhibit angiogenesis have been identified. Molecules produced by normal cells that block angiogenesis may be use...Keywords
This publication has 22 references indexed in Scilit:
- Advancing Current Treatments for CancerScientific American, 1996
- Fighting Cancer by Attacking its Blood SupplyScientific American, 1996
- Cancer statistics, 1995CA: A Cancer Journal for Clinicians, 1995
- Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cellsNature Genetics, 1994
- Interferon–Alpha-2a for the Treatment of Complex Hemangiomas of Infancy and ChildhoodAnnals of Surgery, 1994
- Angiogenesis and Breast CancerHematology/Oncology Clinics of North America, 1994
- Vascular endothelial growth factorTrends in Cardiovascular Medicine, 1993
- Cancer metastasis and angiogenesis: An imbalance of positive and negative regulationCell, 1991
- Multidrug Resistance in CancerScientific American, 1989
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971